对阿拉伯世界炎症性肠病研究的图书统计分析
Shadan AlMuhaidib1, Khalid Bzeizi2, Turki AlAmeel3
1Liver, Digestive, and Lifestyle Health Research Section, and Biostatistics, Epidemiology and Scientific Computing Department, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia.
概括
阿拉伯国家的炎症性肠病 (IBD) 研究正在增加,但落后于全球引用影响和资金. 加强当地支持对于促进研究和解决该地区IBD患病率上升至关重要.
科学领域:
- 图书统计学 图书统计学
- 公共卫生 公共卫生
- 胃肠病学 胃肠病学
背景情况:
- 全球炎症性肠病 (IBD) 的流行率正在上升.
- 阿拉伯国家正在经历IBD病例的增加.
- 这项研究分析了阿拉伯国家的IBD研究成果和趋势.
研究的目的:
- 评估2009-2023年阿拉伯国家IBD研究的研究成果和引用影响.
- 将阿拉伯IBD研究指标与全球平均值进行比较.
- 检查IBD出版物与疾病流行,发病率,GDP和人口之间的关系.
主要方法:
- 从2009年到2023年对出版物的图书统计分析.
- 数据来源于Clarivate Analytics,IHME和世界银行.
- 斯皮尔曼相关性用于分析研究成果与流行病学/经济因素之间的关系.
主要成果:
- 阿拉伯国家制作了1004本IBD出版物 (2.9%的全球产量),以沙特阿拉伯和埃及为首.
- 从2009年到2019年,IBD的发病率和流行率有所增加.
- 与全球平均水平相比,阿拉伯IBD研究显示引用影响 (14.49对23.98) 和资金 (18.7%对32.4%) 较低.
- 在IBD出版物与患病率,发病率和GDP之间发现了显著的正相关性 (P < 0.001).
结论:
- 阿拉伯国家对全球IBD研究做出了重大贡献,但在引用影响和资金方面面临挑战.
- 增加当地投资和支持对于推动阿拉伯世界IBD研究至关重要.
- 解决IBD负担的增加需要改进研究基础设施和合作.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
328
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
328
Inflammatory Bowel Disease I: Ulcerative Colitis
159
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
159
Inflammatory Bowel Disease II: Crohn's Disease
205
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
205
Inflammatory Bowel Disease IV: Pharmacological Management
122
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
122
Chronic Bowel Disorders: Introduction
414
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
414
Inflammatory Bowel Disease V: Surgical Management
133
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
133


